rs72766563

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_032575.3(GLIS2):​c.223G>T​(p.Ala75Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0232 in 1,613,012 control chromosomes in the GnomAD database, including 536 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.018 ( 43 hom., cov: 32)
Exomes 𝑓: 0.024 ( 493 hom. )

Consequence

GLIS2
NM_032575.3 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.395

Publications

5 publications found
Variant links:
Genes affected
GLIS2 (HGNC:29450): (GLIS family zinc finger 2) This gene is a member of the GLI-similar zinc finger protein family and encodes a nuclear transcription factor with five C2H2-type zinc finger domains. The protein encoded by this gene is widely expressed at low levels in the neural tube and peripheral nervous system and likely promotes neuronal differentiation. It is abundantly expressed in the kidney and may have a role in the regulation of kidney morphogenesis. p120 regulates the expression level of this protein and induces the cleavage of this protein's C-terminal zinc finger domain. This protein also promotes the nuclear translocation of p120. Mutations in this gene cause nephronophthisis (NPHP), an autosomal recessive kidney disease characterized by tubular basement membrane disruption, interstitial lymphohistiocytic cell infiltration, and development of cysts at the corticomedullary border of the kidneys.[provided by RefSeq, Jan 2010]
PAM16 (HGNC:29679): (presequence translocase associated motor 16) This gene encodes a mitochondrial protein involved in granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling. This protein also plays a role in the import of nuclear-encoded mitochondrial proteins into the mitochondrial matrix and may be important in reactive oxygen species (ROS) homeostasis. Mutations in this gene cause Megarbane-Dagher-Melike type spondylometaphyseal dysplasia, an early lethal skeletal dysplasia characterized by short stature, developmental delay and other skeletal abnormalities. [provided by RefSeq, May 2017]
PAM16 Gene-Disease associations (from GenCC):
  • autosomal recessive spondylometaphyseal dysplasia, Megarbane type
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002263397).
BP6
Variant 16-4333397-G-T is Benign according to our data. Variant chr16-4333397-G-T is described in ClinVar as [Benign]. Clinvar id is 262085.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0176 (2679/152196) while in subpopulation NFE AF = 0.0254 (1725/67994). AF 95% confidence interval is 0.0244. There are 43 homozygotes in GnomAd4. There are 1337 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 43 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GLIS2NM_032575.3 linkc.223G>T p.Ala75Ser missense_variant Exon 3 of 7 ENST00000433375.2 NP_115964.2 Q9BZE0
GLIS2NM_001318918.2 linkc.223G>T p.Ala75Ser missense_variant Exon 4 of 8 NP_001305847.1 Q9BZE0B3KTH4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GLIS2ENST00000433375.2 linkc.223G>T p.Ala75Ser missense_variant Exon 3 of 7 1 NM_032575.3 ENSP00000395547.1 Q9BZE0
GLIS2ENST00000262366.7 linkc.223G>T p.Ala75Ser missense_variant Exon 4 of 8 2 ENSP00000262366.3 Q9BZE0
PAM16ENST00000577031.5 linkc.292-1623C>A intron_variant Intron 4 of 4 4 ENSP00000459113.1 I3L1U7

Frequencies

GnomAD3 genomes
AF:
0.0176
AC:
2678
AN:
152078
Hom.:
43
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00495
Gnomad AMI
AF:
0.00768
Gnomad AMR
AF:
0.00458
Gnomad ASJ
AF:
0.00490
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00228
Gnomad FIN
AF:
0.0582
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0254
Gnomad OTH
AF:
0.0129
GnomAD2 exomes
AF:
0.0186
AC:
4648
AN:
249892
AF XY:
0.0186
show subpopulations
Gnomad AFR exome
AF:
0.00391
Gnomad AMR exome
AF:
0.00333
Gnomad ASJ exome
AF:
0.00249
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0590
Gnomad NFE exome
AF:
0.0259
Gnomad OTH exome
AF:
0.0156
GnomAD4 exome
AF:
0.0238
AC:
34738
AN:
1460816
Hom.:
493
Cov.:
32
AF XY:
0.0233
AC XY:
16925
AN XY:
726742
show subpopulations
African (AFR)
AF:
0.00355
AC:
119
AN:
33480
American (AMR)
AF:
0.00353
AC:
158
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00302
AC:
79
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00509
AC:
439
AN:
86256
European-Finnish (FIN)
AF:
0.0557
AC:
2919
AN:
52392
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5768
European-Non Finnish (NFE)
AF:
0.0269
AC:
29965
AN:
1111990
Other (OTH)
AF:
0.0174
AC:
1053
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
2071
4142
6214
8285
10356
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1102
2204
3306
4408
5510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0176
AC:
2679
AN:
152196
Hom.:
43
Cov.:
32
AF XY:
0.0180
AC XY:
1337
AN XY:
74424
show subpopulations
African (AFR)
AF:
0.00494
AC:
205
AN:
41522
American (AMR)
AF:
0.00458
AC:
70
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00490
AC:
17
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.00228
AC:
11
AN:
4822
European-Finnish (FIN)
AF:
0.0582
AC:
617
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0254
AC:
1725
AN:
67994
Other (OTH)
AF:
0.0128
AC:
27
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
132
264
396
528
660
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0211
Hom.:
150
Bravo
AF:
0.0131
TwinsUK
AF:
0.0286
AC:
106
ALSPAC
AF:
0.0262
AC:
101
ESP6500AA
AF:
0.00592
AC:
26
ESP6500EA
AF:
0.0246
AC:
211
ExAC
AF:
0.0186
AC:
2261
Asia WGS
AF:
0.00346
AC:
12
AN:
3478
EpiCase
AF:
0.0199
EpiControl
AF:
0.0201

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jul 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Kidney disorder Benign:1
Dec 12, 2016
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nephronophthisis Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nephronophthisis 7 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.098
BayesDel_addAF
Benign
-0.69
T
BayesDel_noAF
Benign
-0.74
CADD
Benign
5.3
DANN
Benign
0.95
DEOGEN2
Benign
0.061
T;T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.099
N
MetaRNN
Benign
0.0023
T;T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
0.20
N;N
PhyloP100
-0.40
PrimateAI
Benign
0.40
T
PROVEAN
Benign
0.10
N;N
REVEL
Benign
0.018
Sift
Benign
0.33
T;T
Sift4G
Benign
0.80
T;T
Polyphen
0.0030
B;B
Vest4
0.081
MPC
0.26
ClinPred
0.0010
T
GERP RS
0.55
Varity_R
0.025
gMVP
0.17
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72766563; hg19: chr16-4383398; COSMIC: COSV52110789; COSMIC: COSV52110789; API